Therefore, in the present study, MMP9 and sST2, promising biomarkers for cardiac fibrosis and hypertrophy, and CRP, a conventional biomarker for inflammation [11], were measured in addition to echocardiography. This evidence concerns the gene MMP9 and hypertrophy.